These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 22382209)

  • 1. Rate of postprocedural stroke and death in SAMMPRIS trial-eligible patients treated with intracranial angioplasty and/or stent placement in practice.
    Siddiq F; Chaudhry SA; Khatri R; Rodriguez GJ; Tummala R; Suri MF; Qureshi AI
    Neurosurgery; 2012 Jul; 71(1):68-73. PubMed ID: 22382209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revisiting angioplasty without stenting for symptomatic intracranial atherosclerotic stenosis after the stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis (SAMMPRIS) study.
    Dumont TM; Kan P; Snyder KV; Hopkins LN; Siddiqui AH; Levy EI
    Neurosurgery; 2012 Dec; 71(6):1103-10. PubMed ID: 22986593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracranial angioplasty and stent placement after stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis (SAMMPRIS) trial: present state and future considerations.
    Qureshi AI; Al-Senani FM; Husain S; Janjua NA; Lanzino G; Lavados PM; Nguyen T; Raymond J; Shah QA; Suarez JI; Suri MF; Tolun R
    J Neuroimaging; 2012 Jan; 22(1):1-13. PubMed ID: 22250951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concurrent comparison of outcomes of primary angioplasty and of stent placement in high-risk patients with symptomatic intracranial stenosis.
    Qureshi AI; Hussein HM; El-Gengaihy A; Abdelmoula M; K Suri MF
    Neurosurgery; 2008 May; 62(5):1053-60; discussion 1060-2. PubMed ID: 18580803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison between primary angioplasty and stent placement for symptomatic intracranial atherosclerotic disease: meta-analysis of case series.
    Siddiq F; Memon MZ; Vazquez G; Safdar A; Qureshi AI
    Neurosurgery; 2009 Dec; 65(6):1024-33; discussion 1033-4. PubMed ID: 19934961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracranial stent placement for symptomatic intracranial stenosis as part of a clinical trial versus outside a clinical trial.
    Siddiq F; Adil MM; Norby K; Qureshi AI
    Stroke; 2013 Dec; 44(12):3571-2. PubMed ID: 24135930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Society for Vascular Surgery Vascular Registry evaluation of stent cell design on carotid artery stenting outcomes.
    Jim J; Rubin BG; Landis GS; Kenwood CT; Siami FS; Sicard GA;
    J Vasc Surg; 2011 Jul; 54(1):71-9. PubMed ID: 21458198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary Angioplasty without Stenting for Symptomatic, High-Grade Intracranial Stenosis with Poor Circulation.
    Wang Y; Ma Y; Gao P; Chen Y; Yang B; Jiao L
    AJNR Am J Neuroradiol; 2018 Aug; 39(8):1487-1492. PubMed ID: 29976834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detailed analysis of periprocedural strokes in patients undergoing intracranial stenting in Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS).
    Fiorella D; Derdeyn CP; Lynn MJ; Barnwell SL; Hoh BL; Levy EI; Harrigan MR; Klucznik RP; McDougall CG; Pride GL; Zaidat OO; Lutsep HL; Waters MF; Hourihane JM; Alexandrov AV; Chiu D; Clark JM; Johnson MD; Torbey MT; Rumboldt Z; Cloft HJ; Turan TN; Lane BF; Janis LS; Chimowitz MI;
    Stroke; 2012 Oct; 43(10):2682-8. PubMed ID: 22984008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Have medical therapy and stenting been fairly compared? A repercussion upon termination of recruitment in the SAMMPRIS trial.
    Leung TW; Yu SC; Wong KS
    Int J Stroke; 2011 Aug; 6(4):312-4. PubMed ID: 21745340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thirty-Day Outcomes of Resolute Onyx Stent for Symptomatic Intracranial Stenosis: A Multicenter Propensity Score-Matched Comparison With Stenting Versus Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis Trial.
    Siddiq F; Nunna RS; Beall JM; Khan I; Khan M; Tekle WG; Ezzeldin M; Tanweer O; Burkhardt JK; Jabbour PM; Tjoumakaris SI; Herial NA; Siddiqui AH; Grandhi R; Martin RL; Qureshi AI; Hassan AE
    Neurosurgery; 2023 Jun; 92(6):1155-1162. PubMed ID: 36700730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carotid stenting with distal protection in high surgical risk patients: the BEACH trial 30 day results.
    White CJ; Iyer SS; Hopkins LN; Katzen BT; Russell ME;
    Catheter Cardiovasc Interv; 2006 Apr; 67(4):503-12. PubMed ID: 16548004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of SAMMPRIS on the future of intracranial atherosclerotic disease management: polling results from the ICAD symposium at the International Stroke Conference.
    Zaidat OO; Castonguay AC; Nguyen TN; Becker KJ; Derdeyn CP; Nelson PK; Amarenco P; Brott TG
    J Neurointerv Surg; 2014 Apr; 6(3):225-30. PubMed ID: 23563478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of primary angioplasty with stent placement for treating symptomatic intracranial atherosclerotic diseases: a multicenter study.
    Siddiq F; Vazquez G; Memon MZ; Suri MF; Taylor RA; Wojak JC; Chaloupka JC; Qureshi AI
    Stroke; 2008 Sep; 39(9):2505-10. PubMed ID: 18658032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of the Vitesse Intracranial Stent Study for Ischemic Therapy (VISSIT) trial in symptomatic intracranial stenosis.
    Zaidat OO; Castonguay AC; Fitzsimmons BF; Woodward BK; Wang Z; Killer-Oberpfalzer M; Wakhloo A; Gupta R; Kirshner H; Eliasziw M; Thomas Megerian J; Shetty S; Yoklavich Guilhermier M; Barnwell S; Smith WS; Gress DR;
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1131-9. PubMed ID: 23261207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Periprocedural risk and long-term outcome of intracranial angioplasty based on a single-centre experience.
    Krajíčková D; Krajina A; Lojík M; Mulačová M; Vališ M
    Vasa; 2013 Jul; 42(4):264-74. PubMed ID: 23823858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the rationale for carotid angioplasty and stenting in patients excluded from NASCET/ACAS or eligible for ARCHeR justified?
    Illig KA; Zhang R; Tanski W; Benesch C; Sternbach Y; Green RM
    J Vasc Surg; 2003 Mar; 37(3):575-81. PubMed ID: 12618695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current status of the management of symptomatic intracranial atherosclerotic disease: the rationale for a randomized trial of medical therapy and intracranial stenting.
    Fiorella D; Turan TN; Derdeyn CP; Chimowitz MI
    J Neurointerv Surg; 2009 Jul; 1(1):35-9. PubMed ID: 21994103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized clinical trial of open-cell vs closed-cell stents for carotid stenting and effects of stent design on cerebral embolization.
    Timaran CH; Rosero EB; Higuera A; Ilarraza A; Modrall JG; Clagett GP
    J Vasc Surg; 2011 Nov; 54(5):1310-1316.e1; discussion 1316. PubMed ID: 21723064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CAPTURE 2 risk-adjusted stroke outcome benchmarks for carotid artery stenting with distal embolic protection.
    Matsumura JS; Gray W; Chaturvedi S; Gao X; Cheng J; Verta P;
    J Vasc Surg; 2010 Sep; 52(3):576-83, 583.e1-583.e2. PubMed ID: 20576398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.